XenoPort Inc

Type: Company

Name: XenoPort Inc

First reported 9 hours ago - Updated 9 hours ago - 1 reports

Shares of XenoPort Receive a Boost, Up...

XenoPort (NASDAQ:XNPT) is one of today's biggest movers, up 2.4% to $7.54. The Dow is trading fractionally lower to 12,956 and the S&P is currently trading fractionally higher to 1,408.XenoPort Inc. is biopharmaceutical company focused on developing a ... [Published Financial News Network online - 9 hours ago]

Entities: XenoPort Inc, Stocks, fractionation

First reported May 22 2013 - Updated May 22 2013 - 5 reports

Apple Inc

XenoPort Resumes Horizant Supply - Analyst Blog

ETFPY dia DELL DIS DKK EAT et dgp DRI dsdfs DVR AAPL eeb SPY efii GOOG ETF ETFC AXP nflx ... [Published Zecco - May 22 2013]

Entities: XenoPort Inc, Apple Inc, Google Inc

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Manufacturing

XenoPort Releases Update on Availability of Horizant

XenoPort, Inc. announced that shipments of Horizant (gabapentin enacarbil) Extended-Release Tablets to its distributor in the United States have commenced. Depending on individual pharmacy ordering patterns, the product is anticipated to be generally ... [Published Individual.com - May 22 2013]

Entities: XenoPort Inc, Neurontin, Ronald W Barrett, Manufacturing, Patient

First reported May 21 2013 - Updated May 21 2013 - 4 reports

XenoPort Inc

XenoPort Candidate Disappoints - Analyst Blog

GOOG eeb DVR DRI AXP dgp et DIS ETFPY EAT DELL dia dsdfs nflx efii ETF ETFC DKK SPY AAPL ... [Published Zecco - May 21 2013]

Entities: XenoPort Inc, Apple Inc, Google Inc

First reported May 20 2013 - Updated May 21 2013 - 2 reports

Alaska Air Group Inc

Stocks to Watch: National Bank of Greece (ADR)(NYSE:NBG), Team, Inc. (NYSE:TISI), XenoPort, Alaska Air Group

Austin, TX -- (SBWIRE) -- 05/21/2013 -- Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following stock:-National Bank ... [Published SBWire - May 21 2013]

Entities: Alaska Air Group Inc, Team Inc, XenoPort Inc, New York Stock Exchange, National Bank of Greece SA

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Downgrade Alert for XenoPort (XNPT)

(Comtex SmarTrend(R)) XenoPort (NASDAQ:XNPT) was downgraded from Outperform to Neutral at Wedbush today. The stock closed yesterday at $5.72 on volume of 3.4 million shares, above average daily volume of 437,000. XenoPort Inc. is biopharmaceutical company ... [Published Individual.com - May 21 2013]

Entities: XenoPort Inc, Comtex, Stocks

First reported May 20 2013 - Updated May 20 2013 - 1 reports

ACADIA Pharmaceuticals Inc

Healthcare Review: Peregrine Pharmaceuticals, XenoPort,Gilead Sciences, Affymax, ACADIA Pharmaceuticals

U.S. stocks were little changed on Monday as acquisition activity gave support but investors were reluctant to rush into the market with indexes hovering around record levels. Deals including Yahoo's $1.1 billion bid for Tumblr indicate that companies ... [Published BioMedReports - May 20 2013]

Entities: ACADIA Pharmaceuticals Inc, Affymax Inc, XenoPort Inc, Peregrine Pharmaceuticals Inc, Gilead Sciences Inc

First reported May 20 2013 - Updated May 20 2013 - 2 reports

Red Hat, JA Solar, Xenoport are big movers

Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market ... [Published Omaha World-Herald - May 20 2013]

Entities: XenoPort Inc, JA Solar Holdings Co Ltd, Red Hat Inc

First reported May 20 2013 - Updated May 20 2013 - 12 reports

XenoPort Sinks as Spasticity Drug for MS Fails in Study

May 20 (Bloomberg) -- XenoPort Inc., the maker of the drug Horizant for Restless Legs Syndrome, sank the most in almost three years after an experimental medicine failed to meet goals of a late-stage clinical trial.XenoPort dropped 15 percent to $5.72 ... [Published La Repubblica - May 20 2013]

Entities: XenoPort Inc, Spasticity, Multiple Sclerosis, Brian Abrahams, Drugs

First reported May 20 2013 - Updated May 20 2013 - 1 reports

XenoPort Trading Lower on Heavy Volume, Inline With Overall Trend (XNPT)

XenoPort shares are trading on heavy volume today, having fallen 12.1% to $5.93. Approximately 1.7 million shares have changed hands today vs. average 30-day volume of 437,000 shares. Unusually high volume can signify a potential turning point or validate ... [Published Comtex SmarTrend - May 20 2013]

Entities: XenoPort Inc, Stocks, watchlist

First reported May 20 2013 - Updated May 20 2013 - 1 reports

Shares of XenoPort Under Pressure, Down 11.0%

(Financial News Network On) One of today's notable stocks in decline is XenoPort (NASDAQ:XNPT), down 11.0% to $6.01. The Dow Jones Industrial Average is now trading fractionally lower to 15,352 and the S&P is trading fractionally higher to 1,668. P ... [Published Individual.com - May 20 2013]

Entities: XenoPort Inc, Stocks, fractionation

First reported May 17 2013 - Updated May 17 2013 - 2 reports

XenoPort, Inc. (XNPT) Provides Update on Availability of Horizant

Staying up-to-date has never been simpler. Sign up for the today! SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today that shipments of HorizantÂ® (gabapentin enacarbil) Extended-Release Tablets to its distributor in the ... [Published BioSpace - May 17 2013]

Entities: XenoPort Inc, Neurontin, Patient

Quotes

...distribution center, which will be filling orders from wholesalers shortly," commented Ronald W Barrett, Ph D , chief executive officer of XenoPort. "We have received inquiries from patients and physicians about the status of Horizant, hence our desire to make today's announcement."

XenoPort Releases Update on Availability of Horizant [Published Individual.com - May 22 2013]

Ronald W Barrett, Ph D , chief executive officer of XenoPort, stated, "We are obviously disappointed that the co-primary efficacy endpoints were not met. Based on the results of the study, we have decided to terminate further investment in this program. We will be working diligently to shut down all activities related to AP development, and plan to provide an update in the future on the impact of these expected savings on our cash burn guidance."

Given Imaging Announces New Data On SmartPill(R); XenoPort Reports Top-Line Results of Phase 3 Tr ... [Published BioMedReports - May 21 2013]

"This is disappointing, given (the drug's) promising mid-stage data," Wells Fargo analyst Brian Abrahams wrote in a note to clients. "We had modeled sales of $77 million by 2017 for the product."

XenoPort to drop multiple sclerosis drug, shares fall [Published 92.9 WLMI - May 20 2013]

"We are obviously disappointed that the co-primary efficacy endpoints were not met," CEO Ronald Barrett said. "We will be working diligently to shut down all activities related to AP development, and plan to provide an update in the future on the impact of these expected savings on our cash burn guidance. We remain committed to allocating our resources to build value through the focused commercialization of Horizant and advancing the development of our novel fumarate product candidate, XP23829."

XenoPort shares skid after MS drug proves to be a lemon in PhIII [Published FierceBiotech - May 20 2013]

More Content

sort by: Date \| Relevance
Shares of XenoPort Receive a Boost, Up... [Published Financial News Network online - 9 hours ago]
XenoPort Resumes Horizant Supply - Analyst Blog [Published Zecco - May 22 2013]
XenoPort Resumes Horizant Supply - Analyst Blog [Published Zecco - May 22 2013]
XenoPort Resumes Horizant Supply - Analyst Blog [Published Zecco - May 22 2013]
XenoPort Resumes Horizant Supply - Analyst Blog [Published Zecco - May 22 2013]
XenoPort Resumes Horizant Supply Zacks [Published Yahoo! Finance - May 22 2013]
XenoPort Releases Update on Availability of Hor... [Published Individual.com - May 22 2013]
XenoPort Candidate Disappoints - Analyst Blog [Published Zecco - May 21 2013]
XenoPort Candidate Disappoints - Analyst Blog [Published Zecco - May 21 2013]
XenoPort Candidate Disappoints - Analyst Blog [Published Zecco - May 21 2013]
XenoPort Candidate Disappoints - Analyst Blog [Published Zecco - May 21 2013]
Stock Analysts’ Ratings Reiterations for May, 2... [Published American Banking News - May 21 2013]
Stocks to Watch: National Bank of Greece (ADR)(... [Published SBWire - May 21 2013]
Downgrade Alert for XenoPort (XNPT) [Published Individual.com - May 21 2013]
Given Imaging Announces New Data On SmartPill(R... [Published BioMedReports - May 21 2013]
Healthcare Review: Peregrine Pharmaceuticals, X... [Published BioMedReports - May 20 2013]
4 Healthcare Stock Stories Prescribed For Inves... [Published Wall St. Cheat Sheet - May 20 2013]
Red Hat, JA Solar, Xenoport are big movers [Published Omaha World-Herald - May 20 2013]
Red Hat, JA Solar, Xenoport are big movers [Published Minneapolis Star Tribune - May 20 2013]
XenoPort Sinks as Spasticity Drug for MS Fails ... [Published La Repubblica - May 20 2013]
UPDATE 2-XenoPort to drop multiple sclerosis dr... [Published Reuters - May 20 2013]
Unusual 11 Mid-Day Movers 05/20: (AQ) (MEAD) (R... [Published Street Insider - May 20 2013]
XenoPort's CEO Presents at Special Conference (... [Published Seeking Alpha - May 20 2013]
Today's Market View: AFFY, OSIS, XNPT, AU [Published SBWire - May 20 2013]
U.S Market Shares : TISI, XNPT, WCRX, WBSN [Published SBWire - May 20 2013]
XenoPort to drop multiple sclerosis drug, share... [Published 92.9 WLMI - May 20 2013]
UPDATE 3-XenoPort to drop multiple sclerosis dr... [Published London South East - May 20 2013]
XenoPort to drop multiple sclerosis drug, share... [Published Yahoo! UK and Ireland - May 20 2013]
XenoPort MS treatment fails in late-stage testing [Published Yahoo! Finance - May 20 2013]
XenoPort Trading Lower on Heavy Volume, Inline ... [Published Comtex SmarTrend - May 20 2013]

sort by: Date \| Relevance
4 Healthcare Stock Stories Prescribed For Inves... [Published Wall St. Cheat Sheet - May 20 2013] AbbVie ( NYSE: ABBV ): Closing price $46.26 On Monday, AbbVie announced the beginning of a Phase 3 clinical study named SONAR (Study Of Diabetic Nephropathy with Atrasentan) to evaluate the effects of the investigational compound atrasentan, when ...
US EQUITY OPENING NEWS INCLUDING: Boeing is loo... [Published Proactiveinvestors United Kingdom website - May 20 2013] US equities point to a broadly unchanged open on Wall Street with a lack of tier-1 data seen during the European morning. Volumes have been thin during the European morning with Switzerland and other smaller European countries closed for the Whit Monday ...
HORIZANT (Gabapentin Enacarbil) Tablet, Extende... [Published DailyMed Drug Label Updates for the last seven ... - May 01 2013] Updated Date: May 1, 2013 EST ...
These 5 Stocks Saw Trading Price Swings This Pa... [Published Wall St. Cheat Sheet - Apr 28 2013] Eli Lilly & Co. ( NYSE:LLY ) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share increased 23.91% to $1.14 in the quarter versus EPS of $0.92 in the year-earlier ...
3 Healthcare Stock Stories for Friday Perusal [Published Wall St. Cheat Sheet - Apr 12 2013] Warner Chilcott Limited ( NASDAQ:WCRX ): Current price $14.20 The firm announced Friday that the FDA has okayed a 200 mg strength of Doryx (doxycycline hyclate) Delayed-Release Tablets. The tablets are a tetracycline-class oral antibiotic. Warner ...